X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fenofibric acid (147) 147
humans (69) 69
index medicus (65) 65
pharmacology & pharmacy (56) 56
fenofibrate (48) 48
fenofibrate - analogs & derivatives (45) 45
male (44) 44
female (30) 30
middle aged (29) 29
dyslipidemia (28) 28
fenofibrate - therapeutic use (26) 26
adult (25) 25
fenofibrate - pharmacokinetics (22) 22
rosuvastatin (21) 21
hypolipidemic agents - therapeutic use (20) 20
mixed dyslipidemia (20) 20
statins (20) 20
drug therapy, combination (19) 19
simvastatin (19) 19
cholesterol (18) 18
dyslipidemias - drug therapy (18) 18
fenofibrate - blood (18) 18
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (18) 18
animals (17) 17
fenofibrate - administration & dosage (17) 17
lipids (17) 17
triglycerides - blood (17) 17
cardiac & cardiovascular systems (16) 16
chemistry, analytical (16) 16
cholesterol, ldl - blood (16) 16
fenofibrate - adverse effects (16) 16
metabolic syndrome (16) 16
aged (15) 15
coronary-heart-disease (15) 15
fenofibrate - pharmacology (14) 14
pharmacokinetics (14) 14
atorvastatin (13) 13
biochemical research methods (13) 13
cholesterol, hdl - blood (13) 13
drug interactions (13) 13
efficacy (13) 13
hypolipidemic agents - adverse effects (13) 13
hypolipidemic agents - pharmacokinetics (13) 13
safety (13) 13
triglycerides (13) 13
double-blind method (12) 12
gemfibrozil (12) 12
hplc (12) 12
hypolipidemic agents - administration & dosage (12) 12
rosuvastatin calcium (12) 12
bioavailability (11) 11
biochemistry & molecular biology (11) 11
density-lipoprotein cholesterol (11) 11
rats (11) 11
reproducibility of results (11) 11
anticholesteremic agents - therapeutic use (10) 10
cardiovascular-disease (10) 10
chemistry, multidisciplinary (10) 10
ezetimibe (10) 10
micronized fenofibrate (10) 10
risk (10) 10
treatment outcome (10) 10
analysis (9) 9
cardiology (9) 9
dyslipidemias - blood (9) 9
human plasma (9) 9
medicine & public health (9) 9
therapy (9) 9
type-2 diabetes-mellitus (9) 9
abt-335 (8) 8
aqueous-solution (8) 8
c-reactive protein (8) 8
cardiovascular (8) 8
combined hyperlipidemia (8) 8
cross-over studies (8) 8
double-blind (8) 8
drugs (8) 8
fibrates (8) 8
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (8) 8
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (8) 8
hypolipidemic agents - blood (8) 8
metabolism (8) 8
pravastatin (8) 8
secondary prevention (8) 8
sensitivity and specificity (8) 8
time factors (8) 8
adiponectin (7) 7
administration, oral (7) 7
area under curve (7) 7
article (7) 7
atherosclerosis (7) 7
biological availability (7) 7
expression (7) 7
fenofibrate - chemistry (7) 7
hypertriglyceridemia (7) 7
insulin-resistance (7) 7
ketoprofen - chemistry (7) 7
lc-ms/ms (7) 7
leptin (7) 7
lipids - blood (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Polymeric Materials and Polymeric Biomaterials, ISSN 0091-4037, 06/2019, Volume 68, Issue 9, pp. 510 - 515
The target of the present work was to formulate and characterize a fenofibric acid-loaded hyaluronic acid-polyethylene glycol (HA-PEG) polymeric composite to... 
polyethylene glycol | solubility | ternary solid dispersion | Dissolution | fenofibric acid | hyaluronic acid | MATERIALS SCIENCE, BIOMATERIALS | POLYMER SCIENCE | VIVO EVALUATION | STABILITY | PVP | SOLVENT | PROFILE | PHYSICOCHEMICAL CHARACTERIZATION | ORAL BIOAVAILABILITY | MICRONIZATION | SOLID-DISPERSION
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 04/2012, Volume 13, Issue 5, pp. 717 - 722
Journal Article
Chromatographia, ISSN 0009-5893, 6/2016, Volume 79, Issue 11, pp. 685 - 692
Journal Article
Diabetologia, ISSN 0012-186X, 6/2011, Volume 54, Issue 6, pp. 1543 - 1553
The mechanisms involved in the beneficial effects of fenofibrate on the development and progression of diabetic macular oedema (DMO) remain to be elucidated.... 
Diabetic retinopathy | Medicine & Public Health | Human Physiology | Diabetic macular oedema | Metabolic Diseases | Fenofibric acid | Internal Medicine | AMPK | Blood–retinal barrier | Permeability | IL-1β | Retinal pigment epithelium | Blood-retinal barrier | Il-1β | CELLS | BARRIER | IL-1 beta | PATHOGENESIS | TIGHT JUNCTIONS | PROLIFERATIVE DIABETIC-RETINOPATHY | MACULAR EDEMA | ENDOCRINOLOGY & METABOLISM | GROWTH-FACTOR | SECRETION | EXPRESSION | BREAKDOWN | Retinal Pigment Epithelium - metabolism | AMP-Activated Protein Kinases - metabolism | Humans | Fluorescein-5-isothiocyanate - metabolism | Blood-Retinal Barrier - drug effects | AMP-Activated Protein Kinases - drug effects | Dose-Response Relationship, Drug | Retinal Pigment Epithelium - pathology | Fenofibrate - pharmacology | Interleukin-1beta - metabolism | Macular Edema - prevention & control | Retinal Pigment Epithelium - drug effects | Tight Junctions - drug effects | Dextrans - metabolism | Tight Junctions - metabolism | Cell Line | AMP-Activated Protein Kinases - antagonists & inhibitors | Fenofibrate - analogs & derivatives | Fluorescein-5-isothiocyanate - analogs & derivatives | Glucose - pharmacology | Macular Edema - metabolism | Hypolipidemic Agents - pharmacology | Diabetic Retinopathy - metabolism | Blood-Retinal Barrier - metabolism | Diabetic Retinopathy - prevention & control | Cell Membrane Permeability - physiology | Cell Membrane Permeability - drug effects | Aged | Biological Transport - physiology
Journal Article
Xenobiotica, ISSN 0049-8254, 04/2018, Volume 48, Issue 4, pp. 400 - 406
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article